recro pharma inc
(RAH:Stuttgart Stock Exchange)
Transactions by RECRO PHARMA INC (RAH) in the last 6 months
Recro Pharma, Inc. (NasdaqCM:REPH) agreed to acquire Alkermes Gainesville LLC and Daravita Limited from Alkermes Pharma Ireland Limited and Eagle Holdings USA, Inc. for approximately $170 million on March 7, 2015. Recro Pharma will acquire Alkermes Gainesville LLC from Eagle Holdings USA, Inc. and Daravita Limited from Alkermes Pharma Ireland Limited. The consideration will be satisfied by $50 million in cash and receipt by Alkermes Pharma Ireland of up to $120 million ...
Eagle Holdings USA, Inc.
Recro Pharma, Inc. (NasdaqCM:REPH) announced that it has entered into a common stock purchase agreement with new accredited investor, Aspire Capital Fund, LLC, a fund managed by Aspire Capital Partners, LLC for gross proceeds of $10,000,000 on February 2, 2015. The term of the agreement is for a period of 24 months. As part of the transaction, the investor will purchase up to 50,000 shares or up to $500,000 per business day. The shares in the transaction will not be ...
|No competitor information is available for RAH.|
|View Industry Companies|
|Price/Cash Flow||NM||Not Meaningful|